Abliva AB (NEVPF)

0.0374 +0.03 (+274.00%) USD  |  OTCM  |  Dec 16, 16:00
More

Abliva Enterprise Value: 55.64M for Dec. 16, 2024

Enterprise Value Chart

View Enterprise Value for NEVPF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cumulative Total Returns Versus Peers
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Oncopeptides AB --
BioInvent International AB 215.05M
Hansa Biopharma AB 224.30M
BioArctic AB 1.348B
Camurus AB 2.724B

Enterprise Value Related Metrics

Net Income (Quarterly) -1.883M
Total Expenses (Quarterly) 1.914M
EPS Diluted (Quarterly) -0.001
Earnings Yield -17.78%
Normalized Earnings Yield -22.70